Introduction:Brainstem tumors pose a significant challenge in pediatric neurosurgery. Although MRI has advanced non-invasive diagnostics, up to 20% of cases show radiologic-histologic discordance, making stereotactic biopsy an important diagnostic option. This study aimed to assess the safety, diagnostic effectiveness, and clinical significance of stereotactic brainstem biopsy in a large pediatric cohort. Methods:We conducted a multicentric retrospective review of 88 children with intrinsic, non-resectable brainstem lesions who underwent stereotactic biopsy (frame-based or robot-assisted). Demographic data, surgical technique, histopathological diagnosis, and complications were analyzed. Results:Eighty-eight pediatric patients (median age 7 years, range 1.5–17; 54% male) underwent stereotactic brainstem biopsy. The most common presenting symptom was cranial nerve dysfunction, with the pons affected in 76% of cases. Stereotactic frame-based, robot-assisted, and Talairach techniques were used in 10%, 31%, and 59% of cases, respectively. The initial diagnostic yield was 97.7%. The most common diagnoses were high-grade glioma, including diffuse midline glioma (44%), followed by low-grade glioma (41%). The overall complication rate was 9.2%, primarily transient neurological deficits. No procedure-related deaths occurred. The mean follow-up period was 32 months. Conclusion:Stereotactic brainstem biopsy is a safe and effective diagnostic tool in children, offering high diagnostic yield with low morbidity. Continued advances in technique and molecular analysis further enhance its clinical value.
27 January 2025 in Seizure: European Journal of Epilepsy
• Meta-analysis of 207 patients supports RNS efficacy in refractory MTLE; RNS therapy may reduce seizure frequency in patients with refractory MTLE; Some patients with MTLE achieved seizure freedom within 6 months with RNS.